• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Development of novel anticancer strategy by combining immunotherapy and surgery in gastrointestinal tumors

Research Project

  • PDF
Project/Area Number 21591648
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionNara Medical University

Principal Investigator

SHO Masayuki  奈良県立医科大学, 医学部, 准教授 (50364063)

Project Period (FY) 2009 – 2011
Keywords外科総論
Research Abstract

Memory T cells are well known to be critically important for host defence in humans. Although they have been also suggested to play a significant role in tumor immunity, their clinical importance remains largely unknown. In this study, we tried to reveal the clinical significance of tumor-infiltrating CD45RO+memory T cells in several gastrointestinal malignancies. We performed immunohistochemistry on gastrointestinal cancer tissues including pancreatic, esophageal, and gastric cancer. Then we counted the cells stained positively for CD45RO+infiltrating into cancer tissue. As a result, CD45RO+hi patients had a significantly better postoperative prognosis than CD45RO+lo patients. Furthermore, the CD45RO status correlated with local immune activation. We found that tumor-infiltrating CD45RO+memory T cell has a significant independent prognostic value in human pancreatic cancer, and also our data suggested that adaptive immune response is functionally important in this fatal disease. Based … More on these clinical data, we extended our study to examine several novel strategies targeting T cell negative pathway including PD-1 and CTLA-4.In murine tumor models, anti-PD-1 and anti-CTLA-4 mAb had a significant antitumor effect on the prevention of liver metastasis and established tumors. Interestingly, the combination of PD-1 and CTLA-4 blockade displayed significant synergistic antitumor effect and resulted in complete inhibition in almost all mice. Further studies indicated that the combined treatment of PD-1/CTLA-4 blockade induced long-lasting and antigen-specific antitumor effect with resistance to tumor rechallenge. Furthermore, we also evaluated the importance of a recently identified T cell negative costimulator, B7-H3 expression. In human pancreatic cancer, B7-H3 expression was observed in almost all patients. Interestingly, anti-B7-H3 blocking mAb had also significant antitumor effect in vivo, similar to PD-1 and CTLA-4 blockade. A series of our studies provide new insights into targeting T cell negative pathway in tumor immunity and suggest that these promising strategies are potentially effective in human cancers. Less

  • Research Products

    (9 results)

All 2012 2010 2009

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (7 results)

  • [Journal Article] Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma2012

    • Author(s)
      Enomoto K, Sho M, Wakatsuki K, Takayama T, Matsumoto S, Nakamura S, Akahori T, Tanaka T, Migita K, Ito M, Nakajima Y
    • Journal Title

      Clin Exp Immunol

      Volume: 168(2) Pages: 186-91

    • DOI

      doi:10.1111/j.1365-2249.2012.04565.x

    • Peer Reviewed
  • [Journal Article] Clinical importance of B7-H3 expression in human pancreatic cancer2009

    • Author(s)
      Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H, Nakajima Y
    • Journal Title

      Br J Cancer

      Volume: 101(10) Pages: 1709-16

    • Peer Reviewed
  • [Presentation] 最新の知見に基づいたT細胞制御による新規消化器癌治療の可能性2010

    • Author(s)
      庄雅之
    • Organizer
      第18回日本消化器関連学会週間
    • Place of Presentation
      横浜
    • Year and Date
      2010-10-15
  • [Presentation] 腫瘍特異的メモリー細胞誘導による新たな癌免疫療法の可能性とその臨床的意義2010

    • Author(s)
      庄雅之
    • Organizer
      第65回日本消化器外科学会総会
    • Place of Presentation
      下関
    • Year and Date
      2010-07-14
  • [Presentation] 難治性消化器癌に対する新規癌治療戦略としてのメモリーT細胞の意義2010

    • Author(s)
      庄雅之
    • Organizer
      第110回日本外科学会定期学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2010-04-08
  • [Presentation] Prognostic significance of CD45RO+memory T cell in pancreatic cancer2009

    • Author(s)
      Sho M, et al.
    • Organizer
      40^<th> Anniversary Joint Meeting of the American Pancreatic Association and Japan Pancreas Society
    • Place of Presentation
      Hawaii, USA
    • Year and Date
      2009-11-04
  • [Presentation] 消化器癌における腫瘍,内浸潤メモリーT細胞の臨床的意義と新規癌治療戦略の可能性2009

    • Author(s)
      庄雅之
    • Organizer
      第47回日本癌治療学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2009-10-22
  • [Presentation] 消化器癌における腫瘍内浸潤メモリーT細胞の臨床的意義2009

    • Author(s)
      庄雅之
    • Organizer
      第95回日本消化器病学会総会
    • Place of Presentation
      札幌
    • Year and Date
      2009-05-07
  • [Presentation] Clinical importance and therapeutic potential of targeting B7-H3 in pancreatic cancer2009

    • Author(s)
      Yamato I, Sho M, et al.
    • Organizer
      American Association for Cancer Research
    • Place of Presentation
      Denver, CO, USA
    • Year and Date
      2009-04-18

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi